Patient Pathfinder: Clinical Trials
Clinical Trials for Melanoma
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 451 active Melanoma trials
Atorvastatin for Preventing Disease Metastasis in Patients With Resected High-Risk Stage IIA Melanoma
Study Type: Interventional Phase 2
A Clinical Study of V940 Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)
Study Type: Interventional Phase 3
Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma
Study Type: Interventional Phase 2
Intratumoral PH-762 for Cutaneous Carcinoma
Study Type: Interventional Phase 1
A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma
Study Type: Interventional Phase 3
Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma
Study Type: Interventional Phase 2
Exercise to Boost Response to Checkpoint Blockade Immunotherapy
Study Type: Interventional
Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors
Study Type: Interventional Phase 1
There are 451 active Melanoma trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now